These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33151506)

  • 21. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
    Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
    PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Kagimoto A; Tsutani Y; Okada M
    Ann Surg Oncol; 2021 Apr; 28(4):2076-2077. PubMed ID: 32965613
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of local recurrence of lung cancer and possibilities for surgical management.
    Stojiljkovic D; Mandaric D; Miletic N; Stojsic J; Markovic I; Gavrilovic D; Pupic G; Stojiljkovic T; Lukac B; Dzodic R
    J BUON; 2013; 18(1):169-75. PubMed ID: 23613403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of KRAS and EGFR gene mutations on recurrence and survival in patients with surgically resected lung adenocarcinomas.
    Sonobe M; Kobayashi M; Ishikawa M; Kikuchi R; Nakayama E; Takahashi T; Menju T; Takenaka K; Miyahara R; Huang CL; Okubo K; Bando T; Date H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S347-54. PubMed ID: 21607772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation.
    Sonoda D; Mikubo M; Shiomi K; Satoh Y
    Ann Thorac Surg; 2017 Feb; 103(2):e119-e120. PubMed ID: 28109367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.
    Tomizawa K; Ito S; Suda K; Fukui T; Usami N; Hatooka S; Kuwano H; Yatabe Y; Mitsudomi T
    Lung Cancer; 2013 Apr; 80(1):99-101. PubMed ID: 23279872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K-ras mutation.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    Thorac Cancer; 2017 May; 8(3):229-237. PubMed ID: 28322512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
    Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
    Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
    Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
    Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.
    Nishii T; Yokose T; Miyagi Y; Daigo Y; Isaka T; Furumoto H; Ito H; Murakami S; Kondo T; Saito H; Oshita F; Yamada K; Matsukuma S; Nakayama H; Masuda M
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e204-e211. PubMed ID: 27349355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASO Author Reflections: TP53 and PKD Co-mutations Were Associated with Poorer Prognoses in Patients with Resected EGFR-Mutated Lung Adenocarcinoma.
    Long H; Liu DH
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):853-854. PubMed ID: 31741107
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.
    Deng C; Zhang Y; Fu F; Ma X; Wen Z; Ma Z; Wang S; Li Y; Chen H
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1223-1231. PubMed ID: 34172990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer.
    Yang X; Liu Y; Mani H; Olson J; Clawson G; Caruso C; Bruggeman R; Varlotto JM; Zander DS; Rassaei N
    Pathol Oncol Res; 2017 Jan; 23(1):73-77. PubMed ID: 27411924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advance in pulmonary adenocarcinoma with micropapillary pattern].
    ZHANG J; LIANG ZY; LIU TH
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):202-5. PubMed ID: 21575400
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.